1Ainiala H,Loukkola J,Peltola J,et al.The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus[J].Neurology,2001,57(3):496-500.
2Tincant A,Brey R,Balestrieri G,et al.International survey on the management of patients with SLE.II.The results of a questionnaire regarding neuropsychiatric manifestations[J].Clin Exp Rheumatol,1996,14(suppl):S23-S29.
3Sanna G,Bertolaccini ML,Cuadrado MJ,et al.Neuropsychiatric manifestations in systemic lupus erythematosus:prevalence and association with antiphospholipid antibodies[J].J Rheumatol,2003,30(5):985-992.
4Sanna G,Bertolaccini ML,Cuadrado MJ,et al.Central nervous system involvement in the antiphospholipid (Hughes) syndrome[J].Rheumatology(Oxford),2003,42(2):200-213.
5Sanna G,Bertolaccini ML,Cuadrado MJ,et al.Neuropsychiatric manifestations in systemic lupus erythematosus:prevalence and association with antiphospholipid antibodies[J]. J Rheumatol,2003,30(5):985-992.
6Sun SS,Huang GWS,Chen JJ,et al.Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT[J].Eur Radiol,2004,14(7):1311-1315.
7Salmi HH,Shalaby MA,Ageely HM,et al.A case of neuropsychiatric lupus with myelopathy successfully treated with corticosteroids[J].West Afr J Med,2004,23(2):173-175.
8Funauchi M,Ohno M,Nozaki Y,et al.Intrathecal corticosteroids for systemic lupus erythematosus with central nervous system involvement[J].J Rheumatol,2003,30(1):207-208.
9Sakic B,Kolb B,Whishaw IQ,et al.Immunosuppression prevents neuronal atrophy in lupus-prone mice:evidence for brain damage induced by autoimmune disease[J].J Neuroimmunol,2000,111(1-2):93-101.
10Petri M,Jones RJ,Brodsky RA.High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus[J].Arthritis Rheum,2003,48(1):166-173.
